Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 271 AL 285

Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine

Mancuso C, Siciliano R, Barone E, Preziosi P.

Biochim Biophys Acta. 2012 May;1822(5):616-24. doi: 10.1016/j.bbadis.2011.09.004. Epub 2011 Sep 14.

A review of the effects of memantine on clinical progression in Alzheimer's disease

Wilkinson D.

Int J Geriatr Psychiatry. 2012 Aug;27(8):769-76. doi: 10.1002/gps.2788. Epub 2011 Oct 1.

Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease

Williams RJ, Spencer JP.

Free Radic Biol Med. 2012 Jan 1;52(1):35-45. doi: 10.1016/j.freeradbiomed.2011.09.010. Epub 2011 Sep 17.

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L.

Arch Neurol. 2012 Feb;69(2):198-207. doi: 10.1001/archneurol.2011.1538. Epub 2011 Oct 10.

Two galantamine titration regimens in patients switched from donepezil

Engedal K, Davis B, Richarz U, Han J, Schäuble B, Andreasen N.

Acta Neurol Scand. 2012 Jul;126(1):37-44. doi: 10.1111/j.1600-0404.2011.01594.x. Epub 2011 Oct 13.

Elevation of glutathione as a therapeutic strategy in Alzheimer disease

Pocernich CB, Butterfield DA.

Biochim Biophys Acta. 2012 May;1822(5):625-30. doi: 10.1016/j.bbadis.2011.10.003. Epub 2011 Oct 12.

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease

Mecocci P, Polidori MC.

Biochim Biophys Acta. 2012 May;1822(5):631-8. doi: 10.1016/j.bbadis.2011.10.006. Epub 2011 Oct 13.

Nanotherapeutics for Alzheimer's disease (AD): Past, present and future

Fazil M, Shadab, Baboota S, Sahni JK, Ali J.

J Drug Target. 2012 Feb;20(2):97-113. doi: 10.3109/1061186X.2011.607499. Epub 2011 Oct 25.

Psychometric evaluation of the Swedish version of the Person-Centered Care Assessment Tool (P-CAT)

Sjögren K, Lindkvist M, Sandman PO, Zingmark K, Edvardsson D.

Int Psychogeriatr. 2012 Mar;24(3):406-15. doi: 10.1017/S104161021100202X. Epub 2011 Nov 1.

α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease

Geerts H.

Expert Opin Investig Drugs. 2012 Jan;21(1):59-65. doi: 10.1517/13543784.2012.633510. Epub 2011 Nov 3.

Amelioration of amyloid β-induced cognitive deficits by Zataria multiflora Boiss. essential oil in a rat model of Alzheimer's disease

Majlessi N, Choopani S, Kamalinejad M, Azizi Z.

CNS Neurosci Ther. 2012 Apr;18(4):295-301. doi: 10.1111/j.1755-5949.2011.00237.x. Epub 2011 Feb 16.

Systemic and central immunity in Alzheimer's disease: therapeutic implications

Butchart J, Holmes C.

CNS Neurosci Ther. 2012 Jan;18(1):64-76. doi: 10.1111/j.1755-5949.2011.00245.x. Epub 2011 Mar 21.

Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial

Ihl R, Tribanek M, Bachinskaya N; GOTADAY Study Group.

Pharmacopsychiatry. 2012 Mar;45(2):41-6. doi: 10.1055/s-0031-1291217. Epub 2011 Nov 15.

γ-Secretase inhibitors and modulators for Alzheimer's disease

Wolfe MS.

J Neurochem. 2012 Jan;120 Suppl 1(Suppl 1):89-98. doi: 10.1111/j.1471-4159.2011.07501.x. Epub 2011 Nov 28.

Developing β-secretase inhibitors for treatment of Alzheimer's disease

Ghosh AK, Brindisi M, Tang J.

J Neurochem. 2012 Jan;120 Suppl 1(Suppl 1):71-83. doi: 10.1111/j.1471-4159.2011.07476.x. Epub 2011 Nov 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias